FDA Roundup: February 28, 2023
FDA Roundup: February 28, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-28-2023
FDA Provides Update on Proposed Human Foods Program and Office of Regulatory Affairs Restructuring
FDA Provides Update on Proposed Human Foods Program and Office of Regulatory Affairs Restructuring
http://www.fda.gov/news-events/press-announcements/fda-provides-update-proposed-human-foods-program-and-office-regulatory-affairs-restructuring
FDA Takes Action to Restrict Unlawful Import of Xylazine
FDA Takes Action to Restrict Unlawful Import of Xylazine
http://www.fda.gov/news-events/press-announcements/fda-takes-action-restrict-unlawful-import-xylazine
ACTUALIZACIÓN: Uso del Dispositivo Renuvion/J-Plasma para determinados procedimientos estéticos: Comunicado de seguridad de la FDA
FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses
FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses
http://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-home-test-detect-both-influenza-and-covid-19-viruses
FDA Roundup: February 24, 2023
FDA Roundup: February 24, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-24-2023
FDA Outlines Steps to Strengthen Tobacco Program
FDA Outlines Steps to Strengthen Tobacco Program
http://www.fda.gov/news-events/press-announcements/fda-outlines-steps-strengthen-tobacco-program
Global Pharma Healthcare Issues Voluntary Nationwide Recall of Delsam Pharma Artificial Eye Ointment Due to Possible Microbial Contamination
FDA Files Civil Money Penalty Complaints Against Four E-Cigarette Product Manufacturers
FDA Files Civil Money Penalty Complaints Against Four E-Cigarette Product Manufacturers
http://www.fda.gov/news-events/press-announcements/fda-files-civil-money-penalty-complaints-against-four-e-cigarette-product-manufacturers